Auxilius launches Atlas Trial Planning Suite for earlier trial budgeting

Auxilius introduced Atlas Trial Planning Suite on September 1, 2026, giving biotech and pharma finance teams a way to build defensible study budgets before trial execution begins. The company says the new suite can generate a budget in minutes and ties early planning into its existing platform for tracking spend once a study starts.

Why it matters: - Auxilius is pushing trial budgeting earlier in the development cycle, where finance teams need usable numbers before protocols are locked or contracts are in place. - The launch aims to reduce reliance on scratch-built models and outdated spreadsheets for long-range trial planning. - The same planning data can carry into trial execution, which may help keep budgets aligned as studies change.

What happened: - Auxilius on September 1, 2026 announced Atlas Trial Planning Suite, a new addition to its clinical trial financial management platform. - The suite extends Auxilius further upstream into pre-study budgeting and benchmarking. - Auxilius plans to demonstrate Atlas live at a virtual product event on September 16 at 1:30 p.m. ET.

The details: - Atlas turns roughly 15 inputs into a study budget in under 10 minutes. - The system uses proprietary multi-source benchmark rates indexed by indication, phase and region. - Atlas also incorporates a sponsor’s historic study data, which Auxilius says is structured and made available for reuse for the first time. - Teams can clone a plan, change site count or region, and compare scenarios side by side as assumptions shift. - For clinical operations, Atlas is designed to support contracting with procedure- and visit-level assumptions instead of a top-line average. - The suite offers well over 100 inputs that users can override. - Auxilius’s core platform already manages active studies after a trial starts, tracking spend when enrollment runs ahead of or behind assumptions, sites open late, protocols are amended, or a CRO underdelivers. - Atlas hands off directly into that existing platform so the plan can continue to evolve after trial launch.

Between the lines: - The launch positions Auxilius against older trial-planning workflows built around detailed contracting, while emphasizing a faster planning stage for finance. - The company is betting that sponsors want one connected data thread across planning, contracting, tracking and closeout instead of separate tools and spreadsheets. - Co-founder and CEO Adam Weisman said the goal is to bridge fast long-range planning and detailed contracting, and to hold every dollar of trial spend on a single thread of data.

What's next: - Auxilius will use the September 16 virtual event to show how Atlas works in practice. - The company says Atlas is the first step toward a broader platform for planned, contracted, tracked and closed trial spend.

The bottom line: - Auxilius is trying to make trial budgeting faster at the front end and more connected across the full life of a study.